RxDoctor Payments Data

Sasidhar Kilaru, MD

Vascular Surgery · Cincinnati, OHNPI 1235104985

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $28,845 of the $32,751 with a category attached, or 88.1%. 13 manufacturers reported payments, led by Stryker at 59.2% of the total. Reporting peaked in 2023 at $10,175 and has fallen 95.6% since, to $448 in 2025. Among vascular surgery clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,751in general payments, 2019–2025

Across 51 payments — averaging $642.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$19K
  • Medical Device Business Services, Inc.$6K
  • Atricure, Inc.$3K
  • Abbott$1K
  • Silk Road Medical, Inc.$804
  • Medtronic$527
  • plus $1K from 7 others
$299,390in research payments, 2019–2025

Across 305 payments — averaging $981.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Surmodics, Inc.$280K
  • Intact Vascular, Inc.$19K
  • Philips North America LLC$900

What the payments were for

  • Consulting fees$28,84588%
  • Travel & lodging$4441%
  • Food & beverage$3,46211%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,751 in reported general payments places this provider in the 90th percentile of 213 vascular surgery providers in Ohio.

See all vascular surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$228,932
Medicare patients
1,586
Services billed
2,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$7,555
ClopidogrelClopidogrel Bisulfate22$320

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →